New genome sequencing algorithm boosts human genome completeness by 20%, improving variant detection and advancing personalized medicine.

NSCLC remains the leading cause of cancer-related mortality worldwide, with EGFR mutations being a critical driver in approximately 10-15% of lung adenocarcinomas in Western populations, and up to 40% ...

Living organisms share an ancestor called the last universal common ancestor, or LUCA. LUCA is estimated to have lived ...

Personalized Gene Editing Saves Baby in Record Time In early 2025, researchers successfully treated a baby boy with a rare, life-threatening disease by giving him a version of the CRISPR gene editor ...

EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight ...

Current trial data suggest that many MCED tests demonstrate high specificity, often above 99% thereby reducing the likelihood of false positives ...

AI in Pathology Market OverviewThe global AI in pathology market is anticipated to witness robust expansion, growing at an ...

OpenClaw creator Peter Steinberger said specialized AI, not AGI or LLMs, is a better future for the technology.

In A Nutshell Harvard researchers developed BrainIAC, a single AI model that can be adapted to analyze brain scans for conditions from Alzheimer’s to cancer, eliminating the need to build separate ...

Digital Pathology Market OverviewThe global digital pathology market is projected to grow at a robust compound annual growth rate of approximately 10.5% through 2029, driven by rapid technological ...

Study links lifelong lead exposure to 18% of US dementia cases, showing bone lead—not blood levels—may predict Alzheimer’s risk decades later.

Report Ocean, a leading strategic consulting and market research firm, in its recent study, estimated Europe Genomic Cancer Panel and Profiling Market size by value at USD 2.62 billion in 2023. During ...